Recalculation of warrants in series TO5
Due to the issuance of new shares in the rights issue announced on January 29, 2021, Brighter AB (publ) has, in accordance with the terms and conditions of the TO5 Brighter warrants, carried out a recalculation of the TO5 warrants. Changes have been made to both the subscription price of the warrants and the number of Brighter shares that each warrant entitle subscription for. Information on the recalculated terms is shown below:
Recalculation of warrants Series TO5
The subscription price in the TO5 series is, after recalculation, SEK 6.20 per share. Prior to the recalculation, the subscription price was SEK 6.40 per share.
The number of Brighter shares that each warrant in the TO5 series entitles subscription for after the recalculation is 1.7. Prior to the recalculation, 1 warrant entitled subscription of 1.65 shares.
The remaining subscription periods in series TO5 are:
- 21 May – June 4, 2021
- 22 November – 6 December, 2021
- 23 May – 6 June, 2022
- 21 November – 5 December, 2022
- 23 May – 5 June, 2023
Complete terms can be found on Brighter's website: https://brighter.se/investors/share-information/
For further information, please contact:
Investor Relations
IR@brighter.se
Ann Zetterberg, CFO
+46 708 37 21 23
ann.zetterberg@brighter.se
Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.